GSK to ramp up vaccine adjuvant production to 1bn doses
The company will supply the adjuvant to partners’ COVID-19 vaccine candidates, without expecting to profit from sales.
Archives for May 29, 2020
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs